413 filings
Page 2 of 21
8-K
y8k uwzjygcjr
15 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
yn3u ljqn1o
7 Dec 23
Kintara Therapeutics Announces Review of Strategic Alternatives
9:10am
8-K
pf3lf
5 Dec 23
Kintara Therapeutics Granted Extension by Nasdaq to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement
9:10am
8-K
xf05c zyr65
21 Nov 23
Departure of Directors or Certain Officers
7:55am
8-K
0sk97eqpu1f2ana1ri
13 Nov 23
Kintara Therapeutics Announces Fiscal 2024 First Quarter Financial Results and Provides Corporate Update
4:15pm
8-K
krfie9cv0o3fp64o38
31 Oct 23
Kintara Therapeutics Announces Preliminary Topline Results From GBM AGILE Study
8:10am
8-K
7h12nhz
10 Oct 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
tqz8aln5idn3
26 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:09pm
8-K
f9lwvti
19 Sep 23
Entry into a Material Definitive Agreement
4:20pm
424B5
ntcx7fp4
19 Sep 23
Prospectus supplement for primary offering
4:16pm
8-K
hqlzs4ivr97 lqz92a4
18 Sep 23
Kintara Therapeutics Announces Fiscal 2023 Year Financial Results and Provides Corporate Update
4:31pm
8-K
ltp2515
30 Jun 23
Amendments to Articles of Incorporation or Bylaws
5:11pm
8-K
st7heene8amp 0gntm0
15 Jun 23
Submission of Matters to a Vote of Security Holders
3:31pm